Cargando…
Myopericarditis After mRNA COVID-19 Vaccine in a Patient With Recent History of COVID-19
Myopericarditis has been identified as a potential adverse event of several vaccines in the medical literature. Here we present a case of a 30-year-old male who had myopericarditis a week after receiving the second booster dose of the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine. The...
Autores principales: | Elhouderi, Eiman, Elsawalhy, Eman, Kabbani, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224764/ https://www.ncbi.nlm.nih.gov/pubmed/35755512 http://dx.doi.org/10.7759/cureus.25264 |
Ejemplares similares
-
Myopericarditis After BNT162b2 mRNA Vaccination With Incidental Intramyocardial Bridging
por: Elghazal, Mohamed, et al.
Publicado: (2023) -
The Association Between COVID-19 Mortality and ICU Admission Rates and Prior History of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use Among Hospitalized COVID-19 Patients With Hypertension in Michigan
por: Elhouderi, Eiman, et al.
Publicado: (2023) -
Myopericarditis Following the Third Dose of COVID-19 mRNA Vaccination: A Case Report
por: Saeed, Aamir, et al.
Publicado: (2023) -
COVID‐19 mRNA vaccines and myopericarditis
por: Gnanenthiran, Sonali R., et al.
Publicado: (2022) -
COVID-19 Vaccine-Induced Pneumonitis, Myositis and Myopericarditis
por: Farooq, Mariya, et al.
Publicado: (2022)